Baker Avenue Asset Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02M | Buy |
12,020
+133
| +1% | +$11.9K | 0.02% | 278 |
|
|
2025
Q4 | $939K | Buy |
11,887
+6,072
| +104% | +$476K | 0.02% | 267 |
|
|
2025
Q3 | $465K | Sell |
5,815
-251
| -4% | -$21.4K | 0.01% | 367 |
|
|
2025
Q2 | $551K | Sell |
6,066
-446
| -7% | -$40.7K | 0.02% | 289 |
|
|
2025
Q1 | $610K | Buy |
6,512
+1,677
| +35% | +$150K | 0.02% | 277 |
|
|
2024
Q4 | $440K | Sell |
4,835
-123
| -2% | -$11.7K | 0.01% | 310 |
|
|
2024
Q3 | $515K | Buy |
4,958
+487
| +11% | +$49.6K | 0.02% | 287 |
|
|
2024
Q2 | $434K | Buy |
+4,471
| New | +$412K | 0.01% | 277 |
|
|
2023
Q4 | – | Sell |
-1,636
| Closed | -$116K | – | 572 |
|
|
2023
Q3 | $116K | Sell |
1,636
-71
| -4% | -$5.31K | 0.01% | 404 |
|
|
2023
Q2 | $132K | Sell |
1,707
-415
| -20% | -$32.1K | 0.01% | 388 |
|
|
2023
Q1 | $159K | Sell |
2,122
-3,731
| -64% | -$277K | 0.01% | 366 |
|
|
2022
Q4 | $461K | Buy |
5,853
+140
| +2% | +$10.5K | 0.03% | 254 |
|
|
2022
Q3 | $401K | Sell |
5,713
-253
| -4% | -$19.8K | 0.03% | 255 |
|
|
2022
Q2 | $478K | Buy |
5,966
+174
| +3% | +$13.6K | 0.03% | 218 |
|
|
2022
Q1 | $439K | Sell |
5,792
-281
| -5% | -$22.3K | 0.02% | 231 |
|
|
2021
Q4 | $518K | Buy |
+6,073
| New | +$474K | 0.03% | 222 |
|
|
2021
Q1 | – | Sell |
-2,700
| Closed | -$230K | – | 242 |
|
|
2020
Q4 | $230K | Buy |
+2,700
| New | +$223K | 0.02% | 221 |
|
|
2019
Q4 | – | Sell |
-3,524
| Closed | -$259K | – | 255 |
|
|
2019
Q3 | $259K | Buy |
3,524
+36
| +1% | +$2.61K | 0.02% | 222 |
|
|
2019
Q2 | $250K | Buy |
3,488
+2
| +0.1% | +$142 | 0.02% | 219 |
|
|
2019
Q1 | $238K | Hold |
3,486
| – | – | 0.02% | 227 |
|
|
2018
Q4 | $207K | Sell |
3,486
-32
| -0.9% | -$2K | 0.02% | 233 |
|
|
2018
Q3 | $236K | Hold |
3,518
| – | – | 0.02% | 239 |
|
|
2018
Q2 | $228K | Sell |
3,518
-254
| -7% | -$16.6K | 0.02% | 229 |
|
|
2018
Q1 | $270K | Sell |
3,772
-214
| -5% | -$15.4K | 0.02% | 223 |
|
|
2017
Q4 | $301K | Buy |
3,986
+400
| +11% | +$29.2K | 0.03% | 211 |
|
|
2017
Q3 | $261K | Hold |
3,586
| – | – | 0.03% | 203 |
|
|
2017
Q2 | $266K | Sell |
3,586
-720
| -17% | -$53.5K | 0.04% | 180 |
|
|
2017
Q1 | $315K | Buy |
4,306
+720
| +20% | +$50.4K | 0.04% | 172 |
|
|
2016
Q4 | $235K | Hold |
3,586
| – | – | 0.03% | 187 |
|
|
2016
Q3 | $266K | Sell |
3,586
-48
| -1% | -$3.55K | 0.04% | 173 |
|
|
2016
Q2 | $266K | Buy |
3,634
+48
| +1% | +$3.42K | 0.04% | 171 |
|
|
2016
Q1 | $253K | Hold |
3,586
| – | – | 0.04% | 162 |
|
|
2015
Q4 | $239K | Hold |
3,586
| – | – | 0.03% | 172 |
|
|
2015
Q3 | $228K | Hold |
3,586
| – | – | 0.04% | 173 |
|
|
2015
Q2 | $235K | Buy |
3,586
+600
| +20% | +$40.7K | 0.03% | 221 |
|
|
2015
Q1 | $207K | Hold |
2,986
| – | – | 0.03% | 225 |
|
|
2014
Q4 | $207K | Buy |
+2,986
| New | +$202K | 0.03% | 239 |
|
|
2014
Q3 | – | Sell |
-2,986
| Closed | -$204K | – | 273 |
|
|
2014
Q2 | $204K | Buy |
+2,986
| New | +$200K | 0.03% | 269 |
|
Other funds holding CL
VCM
DAM
VPM
Baker Avenue Asset Management's CL Position: Q1 2026 in Review
Baker Avenue Asset Management increased its Colgate-Palmolive (CL) stake by 1.1% in Q1 2026, buying an estimated $11.9K and bringing the position to 12,020 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #278.
Baker Avenue Asset Management first reported a position in CL in Q2 2014 and has held it in 38 quarters since. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Baker Avenue Asset Management held 12,020 shares of Colgate-Palmolive worth $1.02M as of Q1 2026.
- Baker Avenue Asset Management bought 133 Colgate-Palmolive shares in Q1 2026, an estimated $11.9K.
- Colgate-Palmolive made up 0.02% of Baker Avenue Asset Management's portfolio in Q1 2026, its #278 holding.
- Baker Avenue Asset Management first reported a position in Colgate-Palmolive in Q2 2014 and has held it in 38 quarters since.
- 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Baker Avenue Asset Management's 13F filing for Q1 2026, filed 12 May 2026.